Table 1

MO levels in naive (tumor-free) and 3LL tumor-bearing mice

Treatment group/categoryBone marrow
Peripheral blood
Spleen
Tumor
PercentageCells × 103/femurPercentageCells × 103/mLPercentageCells × 103/spleenPercentageCells/mg tumor
Naive/control 10.7 ± 0.3 1858.7 ± 258.8 2.3 ± 0.2 51.2 ± 7.9 0.9 ± 0.2 609.2 ± 11.1 NA NA 
Naive/GW2580 10.9 ± 0.4 1816.0 ± 136.0 2.5 ± 0.2 56.7 ± 8.8 0.7 ± 0.1 459.7 ± 18.7 NA NA 
P > .3 > .3 > .3 > .3 > .3 < .01   
TB/control 15.2 ± 0.2 2322.9 ± 106.8 4.1 ± 0.9 86.1 ± 23.1 1.6 ± 0.1 1434.1 ± 22.7 11.2 ± 1.9 5662.2 ± 830.5 
TB/GW2580 11.4 ± 0.5 1750.4 ± 100.5 2.5 ± 0.6 52.7 ± 14.9 1.2 ± 0.1 798.2 ± 177.1 2.7 ± 0.8 1459.3 ± 247 
P < .001 < .01 .22 .27 < .05 < .05 < .01 < .01 
Treatment group/categoryBone marrow
Peripheral blood
Spleen
Tumor
PercentageCells × 103/femurPercentageCells × 103/mLPercentageCells × 103/spleenPercentageCells/mg tumor
Naive/control 10.7 ± 0.3 1858.7 ± 258.8 2.3 ± 0.2 51.2 ± 7.9 0.9 ± 0.2 609.2 ± 11.1 NA NA 
Naive/GW2580 10.9 ± 0.4 1816.0 ± 136.0 2.5 ± 0.2 56.7 ± 8.8 0.7 ± 0.1 459.7 ± 18.7 NA NA 
P > .3 > .3 > .3 > .3 > .3 < .01   
TB/control 15.2 ± 0.2 2322.9 ± 106.8 4.1 ± 0.9 86.1 ± 23.1 1.6 ± 0.1 1434.1 ± 22.7 11.2 ± 1.9 5662.2 ± 830.5 
TB/GW2580 11.4 ± 0.5 1750.4 ± 100.5 2.5 ± 0.6 52.7 ± 14.9 1.2 ± 0.1 798.2 ± 177.1 2.7 ± 0.8 1459.3 ± 247 
P < .001 < .01 .22 .27 < .05 < .05 < .01 < .01 

MO levels in naive (tumor-free) and 3LL tumor-bearing mice. Monocyte levels were measured by flow cytometry in the bone marrow, peripheral blood, spleens, and tumors of control and GW2580-treated tumor-free mice (Naive), as well as control and GW2580-treated tumor-bearing mice (TB). Percentages and absolute numbers are represented as mean ± SEM. Monocyte levels from control and GW2580-treated mice were assessed using the Student t test.

NA indicates not applicable.

or Create an Account

Close Modal
Close Modal